MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Jul 2023 Evaluate
The June 2023 quarter revenue stood at Rs. 1477.80 millions, up 14.62% as compared to Rs. 1289.30 millions during the corresponding quarter last year.A humble growth in net profit of 21.36% reported in the quarter ended June 2023 to Rs. 221.00  millions from Rs. 182.10 millions.Operating Profit saw a handsome growth to 340.50 millions from 290.60 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1477.80 1289.30 14.62 1477.80 1289.30 14.62 5128.10 4401.60 16.51
Other Income 18.10 12.20 48.36 18.10 12.20 48.36 48.00 29.90 60.54
PBIDT 340.50 290.60 17.17 340.50 290.60 17.17 1074.90 893.50 20.30
Interest 0.70 1.10 -36.36 0.70 1.10 -36.36 3.10 5.20 -40.38
PBDT 339.80 289.50 17.37 339.80 289.50 17.37 1071.80 888.30 20.66
Depreciation 42.10 38.30 9.92 42.10 38.30 9.92 155.00 156.60 -1.02
PBT 297.70 251.20 18.51 297.70 251.20 18.51 916.80 731.70 25.30
TAX 76.70 69.10 11.00 76.70 69.10 11.00 240.40 216.90 10.83
Deferred Tax -2.50 3.30 -175.76 -2.50 3.30 -175.76 -3.10 -10.70 -71.03
PAT 221.00 182.10 21.36 221.00 182.10 21.36 676.40 514.80 31.39
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.04 22.54 2.23 23.04 22.54 2.23 20.96 20.30 3.26
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..